Business

Pharmaceutical Industry To Grow Between 6-8% In Upcoming Fiscal Year: ICRA Report

The pharmaceutical industry has been witnessing consistent growth. Even after a number of disruptive events, the Indian pharmaceutical industry recorded a healthy CAGR of 10.9 per cent between FY2012 and FY2022. Now, as per the rating agency, ICRA, the domestic pharmaceutical sector is anticipated to see revenue growth of 6–8% in the upcoming fiscal year.

Growth Of the Pharma Industry

ICRA’s Vice President and Sector Head for Corporate Ratings Mythri Macherla said in a statement, “Going forward, ICRA expects revenues for its sample set to increase by 6–8% in FY2024 against 3–4% growth in FY2023.” She continued by speaking about structural factors that are expected to support revenue growth for the industry. Talking about the same, she mentioned the ageing population, the consistent rise in lifestyle/chronic diseases and the WPI-linked increase in prices for NLEM (National List of Essential Medicines) products. Moreover, the new product introductions and increase in annual price for non-NLEM products, which will play a part.

Despite the volume growth of the Indian Pharmaceutical Market that remained at 2-3% since FY18, its growth has largely been supported by increasing prices and introducing new products, Macherla added. Increased sales of anti-infectives have helped support the total domestic pharmaceutical industry. As a result, there was a growth of 14.6% in FY2022, which was aided by price increases implemented to counteract rising raw material cost inflation, she further said. However, the growth decreased by 1.2% for nine months in FY22-23, as stated by ICRA’s report.

The report further mentioned that the measures taken by companies towards introducing new products and enhancements in field force are anticipated to contribute to the growth. Medicines on the National List of Essential Medicines (NLEM) made up 17–18% of the Indian Pharmaceutical Industry, according to ICRA, some businesses obtained around 30% of their income from these medicines. Speaking of emerging trends, e-pharmacies have gained significant traction in recent years and now make up 10-15% of the industry.

 

 

Malika Sahni

Recent Posts

Hina Khan Hails 11 Years Of PM Modi’s Leadership; Highlights National Progress

As the nation marks 11 years under PM Modi's leadership, actress Hina Khan shares her…

13 hours ago

Subhash Ghai Hails PM Modi’s Transformative Vision For India

Subhash Ghai has praised PM Narendra Modi’s leadership for catalysing India’s growth and changing the…

13 hours ago

India & Central Asia Boost Rare Earth Cooperation At Delhi Meet

India and five Central Asian nations have agreed to deepen cooperation on rare earths and…

14 hours ago

PM Modi’s Beej Se Bazaar Tak Vision Reshapes Indian Agriculture

Prime Minister Modi has redefined Indian agriculture with the ‘Beej Se Bazaar Tak’ vision, transforming…

14 hours ago

EV Sales Cross 4% Mark In May; Signalling Steady Shift To Green Mobility

EV sales topped 4% of passenger vehicle retail in May 2025, signalling growing demand for…

15 hours ago

Self-Reliant Defence Industry Marks India’s Strategic Security Ascent

One year into Modi 3.0, reforms have reduced poverty, strengthened defence, and accelerated the digital…

15 hours ago